WaferGen's Q3 Revenues Plummet; Layoffs Planned | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – WaferGen Biosystems today reported a steep drop in its third-quarter revenues and a planned cut of 24 percent of its workforce as part of a revised plan to increase adoption of its SmartChip System.

The Fremont, Calif.-based firm reported total revenues of $89,088 for the quarter ended Sept. 30, compared to $633,241 for the third quarter of 2010.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.